HOLLAND & KNIGHT LLP

Lobbying for NOVO NORDISK, INC. · Pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $60,000.00 income · posted Jan 9, 2026

Lobbying activity 2

Budget/Appropriations

Legislation related to obesity treatments; Advocacy for antiobesity medications.

Health Issues

Legislation related to obesity treatments; Advocacy for antiobesity medications.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.